The Candidiasis drugs in development market research report provides comprehensive information on the therapeutics under development for Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Candidiasis. Buy the report here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Candidiasis and features dormant and discontinued products.
GlobalData tracks 63 drugs in development for Candidiasis by 55 companies/universities/institutes. The top development phase for Candidiasis is preclinical with 35 drugs in that stage. The Candidiasis pipeline has 48 drugs in development by companies and 15 by universities/ institutes. Some of the companies in the Candidiasis pipeline products market are: King’s College London, University of Wisconsin Madison and Basilea Pharmaceutica.
The key targets in the Candidiasis pipeline products market include Ergosterol, Lanosterol 14 Alpha Demethylase, and 1,3 Beta Glucan Synthase.
The key mechanisms of action in the Candidiasis pipeline product include Ergosterol Inhibitor with four drugs in Pre-Registration. The Candidiasis pipeline products include nine routes of administration with the top ROA being Oral and 14 key molecule types in the Candidiasis pipeline products market including Small Molecule, and Monoclonal Antibody.
Candidiasis overview
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash. It will usually be found in areas such as the groin; the folds of the buttocks; between the breasts, toes, or fingers; and in the navel. Treatment includes antifungal drugs.
For a complete picture of Candidiasis’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
